Lucaspye BIO
LucasPye BIO: A leading CDMO, making biotherapeutic drugs affordable and accessible globally through innovative bio-manufacturing services.
Founded
2018LucasPye BIO: A leading CDMO, making biotherapeutic drugs affordable and accessible globally through innovative bio-manufacturing services.
Founded with the mission to make biotherapeutic drugs affordable and accessible globally, LucasPye BIO is a pioneering Contract Development Manufacturing Organization (CDMO). The company specializes in promoting novel biologics, including biosimilars and biobetters, by offering bio-manufacturing services at below-market prices. Their primary clients include Life Science Entrepreneurs, Small Biopharmaceutical Companies, and Non-Profit organizations. LucasPye BIO leverages advanced technologies like E-Doc Cloud-Software to streamline operations and enhance service delivery.
LucasPye BIO has garnered attention for its innovative approach and significant contributions to the biopharmaceutical industry. The company's leadership includes experts with extensive experience in biotechnology and pharmaceuticals. Key achievements include the successful development and manufacturing of cost-effective biologics, which have had a substantial impact on healthcare accessibility. LucasPye BIO's efforts have positioned it as a crucial player in the global biomanufacturing landscape, driving advancements in drug development and production.
Companies similar to Lucaspye BIO include Lumen Bioscience, Arranta Bio, August Bioservices and WuXi Biologics.
Lucaspye BIO was founded in 2018.
Lucaspye BIO's headquarters is located in Philadelphia, PA, US.
Lucaspye BIO's most recent funding round was for $1M (USD) in May 2019.
As of May 1, 2019, Lucaspye BIO has raised a total of $1M (USD).
Lucaspye BIO has 30 employees as of Feb 4, 2024.
augustbio.com
